v" To date, most patients suffering from hydrocephalus have been treated by insertion of differential-pressure valves that have fairly constant resistance. Since intracranial pressure (ICP) is a variable parameter (depending on such factors as patient's position and rapid eye movement sleep) and since cerebrospinal fluid (CSF) secretion is almost constant, it may be assumed that some shunt complications are related to too much or too little CSF drainage. The authors suggest a new approach to treating hydrocephalus, the aim of which is to provide CSF drainage at or below the CSF secretion rate within a physiological ICP range. This concept has led the authors to develop a three-stage valve system. The first stage consists of a medium-pressure lowresistance valve that operates as a conventional differential-pressure valve until the flow through the shunt reaches a mean value of 20 ml/hr. A second stage consists of a variable-resistance flow regulator that maintains flow between 20 and 30 ml/hr at differential pressures of 80 to 350 mm H20. The third stage is a safety device that operates at differential pressures above 350 mm H20 (inducing a rapid increase in CSF flow rate) and therefore prevents hyper-elevated ICP. An in vitro study is described that demonstrates the capability of this system to maintain flow rates close to CSF production under a range of pressures similar to those observed under various human physiological and postural conditions. Promising clinical results in 19 patients shunted with this valve are summarized.
A
LTHOUGH the introduction of one-way calibrated shunt systems in 195268,70 has proven to be a definite advance in the treatment of hydrocephalus, and shunt technology has evolved over the past three decades, 2, 8, 9, 35, 50, 55, 63, 77, 81, 83, 93 ,99 some problems still remain unsolved. The variety of valves available on the market today is partly related to these uncertainties. 8~ Shunt obstruction 1,4,1~ and infection 69,85 are recognized complications associated with prosthesis insertion and have been the subject of many investigations.3"29'37"58 '67"72'73'95 Complications due to under-and overdrainage are directly related to the hydrodynamic characteristics of valves, and have been extensively studied over the past 15 years. 22,25,31,32,38 These phenomena, which had previously been more or less overlooked, are now well documented; they include shunt dependency;23,24.51 slit-ventricle syndrome; 39, 44, 47, 59, 89 subdural hematoma;4S,61. 9o post-shunt craniosvnostosis; 48 spinal canal stenosis; 49 and orthostatic intracranial hypotension. Moreover, it is not known at the present time whether chronic overdrainage is responsible for some of these poor long-term results. 46, 52, 97 Most commercially available shunts include differential-pressure (DP) valves: once the valves are open, flow is determined by the difference between the cerebrospinal fluid (CSF) input and output pressures. 35, 79, 84 Therefore, when the patient is in the upright position, a DP increase ("siphon effect") occurs due to the height of the hydrostatic column between the inlet and the outlet of the shunt. 7,26,53,61A~ Overdrainage can be considered constant in standing patients, since in that position the draining capacity of the shunt exceeds the ventricular CSF secretion rate. Several attempts have been made to remedy this situation, 7, 21, 27, 34, 78, 94, 104 but for various reasons none of the resulting shunts are completely satisfactory.
The purpose of this article is to describe a shunt system based on a new approach in the treatment of hydrocephalus. The hydrodynamic characteristics of the system and results of the first clinical trials are presented. The principle of this valve is to operate as a flow regulator within certain DP values.
Materials and Methods

Valve Specifications
In 1982, Portnoy 76 raised the issue of shunt hydrodynamic characteristics and stated: "Several neurosurgeons have commented that the ideal valve should be flow-controlled. Such a valve would have to continuously determine the CSF formation rate and the rate of outflow through natural channels, and regulate the flow through the valve so as to remove only the excess fluid. There is no mechanism now available that can accomplish this without difficulty, much less be capsuled into a volume of 3 ml or less."
The new valve described in this article is designed on the principle that the flow through the shunt should not exceed the CSF production rate throughout the range of physiological intracranial pressures (ICP's). It is well known that flow through a shunt can be expressed as F = DP/R, where F is flow, DP is the difference between input and output pressure, and R is resistance (Fig. 1) . On the other hand, since the CSF secretion rate is approximately constant, 13-~5,6~
it can be postulated that the excess fluid that is not drained through the natural channels and that has to be evacuated through the shunt is roughly constant at physiological ICP's. Since the DP varies under circumstances such as when the patient is standing erect, or during rapid eye movement (REM),~!eep or exertion, 11, 18, 41, 54, 56, 75, 86 ,103 the resistance of theshunt should vary in order to maintain a constant flow. These considerations led us to design a variable-resistance shunt to comply with the following requirements.
The hydrodynamic specifications included the need for: suitable drainage at different pressures close to the valve-opening pressure (as, for instance, when the patient is in the supine position); reduction or prevention of overdrainage at large DP's (such as when the patient is standing erect, or during straining, exertion, or REM sleep); and inclusion of a safety device to prevent any accidental intracranial hypertension. The construction specifications included the requirements that, if possible, the shunt should contain no metallic material, 6, 66 and that the surfaces in the shunt components should be sterile and be unlikely to cause a reaction. 3~ The design specifications demanded a small size to fit pediatric as well as adult patients, and minimal use of connectors.
The hydrodynamic specifications called for a threestage valve (Fig. 2 left) . Stage I should act as a lowresistance valve. When the DP is low, for instance when the patient is in the supine position, there is no risk of overdrainage as long as the resistance of the shunt is correctly adjusted. Therefore, at the first stage the valve should operate as a conventional DP valve with a preset opening pressure. The valve should remain in this configuration as long as the CSF flow through the shunt does not exceed 20 ml/hr, which is considered to be the average CSF secretion rate. It should achieve this flow rate with a small increase in DP as would a lowresistance valve. 35 Stage II should act as a flow regulator when the DP increases, for instance when the patient is in the uptight position. This means that the shunt drainage capacities should remain between 20 and 25 ml/hr. This flow regulation is obtained by an increase of the valve resistance, which means that a large change in DP will result in only a small variation of the flow rate. 1~ Stage III, the last stage of the system, is a safety device. If for some reason the DP exceeds 30 m m Hg, as in shunt obstruction, CSF oversecretion, or excessive CSF volume under an elevated ICP at the outset of drainage, the shunt should then operate as a low-resistance DP valve as in Stage I. With such a device, ICP cannot exceed the pre-set safety pressure level.
We have designed a compact device, the Orbis-Sigma valve (OSV),* that fulfills all the above-mentioned spec-* Orbis-Sigma valve manufactured by Cordis Corp., Miami, Florida.
ifications (Fig. 3 left) . The operative parts of the valve are shown in Fig. 3 right. A plug with an orifice can travel from Point A to Points B and C along a noncylindrical pin. The plug remains at A as long as the DP is below the opening pressure. When the D P exceeds the opening pressure, the plug moves downward to B, allowing the valve to operate as a low-resistance pressure shunt. The plug remains at B at CSF flow rates of up to 20 ml/hr, and above this value it moves downward to C. The cross-sectional area between the orifice of the plug and its guiding pin decreases abruptly, thereby causing a marked increase of resistance; in this way, the valve operates as a flow regulator. Beyond Point C, the drainage area increases so that the shunt again operates as a low-resistance valve.
In Vitro Test Procedures
To test this new valve in vitro and to compare it to other valves, we used a test bench similar to that designed by Watts and Keith ~~176 (Fig. 4) . This bench allows a testing procedure that takes into consideration the following parameters: the temperature at which the test is performed; the pulsatility of the flow; the compliance of the proximal chamber a8 (Fig. 5) ; and the viscosity of the test fluid. This test bench facilitates long-term testing and therefore simulates the conditions under which the valve operates in vivo. The testing bench of Watts and Keith has been modified by the addition of an external chamber (Fig. 4) that communicates with the distal chamber and can be placed lower: this third chamber can provide negative pressures in the distal chamber, thus simulating a "siphon effect."
Since the tests were time-consuming, some lasting for hours or days, the testing sequences were automatically monitored with a computer. The parameters recorded were: the flow pumped into the proximal chamber (simulating CSF formation); the flow through the tested shunt; the pressures in the proximal and distal chambers; the amplitude and frequency of the pulse when a pulsed flow was utilized; and the temperature of the water bath. The testing procedure included flow rates varying from 0 to 60 ml/hr, with or without pulses at frequencies between 60 and 120/min, and with or without added compliance in the proximal chamber ( 
Clinical Studies
Clinical trials were performed in 19 hydrocephalic patients aged from 2 months to 15 years with the authorization of the ethics committee of Les EnfantsMalades Hospital and with the written or verbal consent of the patients' parents. Half of the patients were older than 2 years. Indications for shunt insertion are listed in Table 1 .
We deliberately selected patients in whom overdrainage would create a high risk of clinical complications, such as those who had post-shunt pericerebral collections or slit ventricles. Whenever possible, long-dura- Sigma is the system presented here; M.P. = medium pressure; L.P. = low pressure; P = pediatric; AHS low P.M.P. = American Heyer-Schulte low-profile medium-pressure valve; DP = differential pressure. tion pre-and postoperative ICP recordings were performed with the child in the supine as well as in the upright position. All the patients underwent the same computerized tomography (CT) scanning protocol: one preoperative scan and several postoperative CT scans (1 week, 1 month, 3 months, and 1 year after surgery).
Results
In Vitro Test Results
Pressure-Flow Characteristics. The pressure-flow characteristics of the tested OSV prototypes, measured with a steady flow rate at 37~ were almost exactly as theoretically expected (Fig. 6) . The opening and closing pressures varied from 4 to 6 mm Hg; the shunt acted as a flow regulator at flows between 25 and 35 ml/hr, and as a low-resistance DP valve at a DP slightly above 30 mm Hg. Figure 7 allows a comparison of results with different DP valves. It shows that, although the opening pressure determines the point where the shunt begins to act, the draining capacity itself does not depend significantly on this opening pressure. These draining capacities are far beyond the normal CSF secretion rates, the discrepancy being larger with lowresistance than with high-resistance valves. 7,79 Being a variable-resistance shunt, the OSV drains barely more OSV Pressure-Flow Characteristics Under Different Conditions. Four different types of valve were tested successively with a steady flow and with a pulsed flow. Pulse amplitude was 7 mm Hg and pulse frequency 100/min. Tests were performed with a rigid proximal chamber. When the mean pressures were compared, there were no significant differences in results obtained with steady and pulsed flow, whatever the type of shunt tested (Fig. 8) . Two test fluids were used in four different shunts (Fig. 9) protein content of the fluid were slight; with the Holter and Heyer-Schulte valves, the pressure for the same flow was moderately increased in the proximal chamber when the protein concentration of the fluid was increased. Under the same conditions, the slope of the second part of the curve was steeper with the OSV. One OSV system was tested continuously for 7 days and the various parameters (steady and pulsed flow, temperature of 20* to 40~ and protein fluid concentration of 5 to 25 gm/liter) were successively modified. The pressure-flow data obtained throughout the testing procedure varied little, and generally retained the S shape of the curve. From these results, it can be concluded that the hydrodynamic characteristics of the OSV remain within very acceptable limits under the conditions tested (Fig. 10) .
Influence of "Siphon Effect" on Flow Rate. To simulate the "siphon effect" observed on shunted patients in the upright position (Fig. 11) , a negative pressure was produced in the distal chamber. Tests were performed with a compliant proximal chamber (60-ml volumetric reserve) 28 (Fig. 5 ). For all the tested shunts, the flow delivered by the pump was maintained at 20 ml/hr throughout the procedure (at the beginning it was zero). Under these conditions, the pressure in the proximal chamber (simulating ICP) reached a plateau at a level that depended on the opening pressure and the resistance of the shunt. This was usually obtained within less than 15 minutes, and the distal-chamber pressure was then reduced to -25 mm Hg.
Under these test conditions, the flow through the low-resistance DP valve ( Fig. 11 upper left) increased to 240 ml/hr; however, as long as this flow was maintained, the pressure drop in the proximal chamber was limited to -4 or -5 mm Hg due to the buffering reserve of this compliant proximal chamber. Later, when this 60-ml reserve was drained off, the compliance of the proximal chamber decreased abruptly. The flow then returned to the 20-ml/hr rate delivered by the pump because practically no extra fluid could be withdrawn from the proximal chamber. Simultaneously, the proximal-chamber pressure dropped to about -17 mm Hg, the level of this negative pressure being determined by the induced negative output pressure and by the shunt resistance.
When an antisiphon device TM was inserted in connection with a low-resistance DP valve ( Fig. 11 upper  right) , the proximal-chamber pressure variations were very different. When the distal-chamber pressure was lowered to -25 mm Hg, the antisiphon device closed, so that for more than 15 minutes the rate of flow through the shunting system dropped below 5 ml/hr while the proximal-chamber pressure increased to + 15 mm Hg. At that point the shunting system reopened, the flow rate returned to 20 ml/hr, and the proximal chamber remained at 15 mm Hg.
With an OSV, when the distal-chamber pressure was reduced to -25 mm Hg the flow rate increased to only 30 ml/hr while pressure in the proximal chamber decreased to -3 mm Hg, at which point flow and pressure were stabilized for a long period of time. In fact, overdrainage was 10 ml/hr (that is, the difference between 30 ml/hr and the 20-ml/hr flow delivered by the pump). Because, with the test equipment, overdrainage has to exceed 60 ml before the compliance of the proximal chamber decreases, the proximal-chamber pressure was stable for 6 hours at about -3 mm Hg.
Influence of Flow Variations. Short-term 20-to 100-ml/hr flow variations were induced to study their effect on the proximal-chamber pressure with low-resistance valves and OSV's (Fig. 12) . With low-resistance valves, the pressure variations were small so that the A new shunt for hydrocephalus 
Clinical Findings
There were no m e c h a n i c a l or infectious complications in this series. In five patients with shunts, variations in ICP were studied successively in the r e c u m b e n t then in the upright position. Figure 13 (Fig. 11) .
system as to the effect of an erect position on ICP in patients with shunts. In the patient with a DP valve (Fig. 13 upper) , ICP dropped to -5 m m Hg, remained at this level for 40 minutes, and then dropped further to -1 4 m m Hg. These data, when compared with the in vitro test results (Fig. 11) , suggest the existence of a 40-minute overdrainage period in this patient. In the patient with an OSV system, ICP in the upright position decreased to -3 m m Hg and remained stable at this level during the entire 4-hour recording session.
In a study of the intracranial biophysical characteristics of each patient and their eventual relationships with ICP and CT changes after shunt insertion, 18 of the 19 patients with an implanted OSV were classified as having acute or chronic hydrocephalus. In the first C. Sainte-Rose, M. D. Hooven and J. F. Hirsch group, both ICP and ventricular size normalized within a few days (Figs. 14 and 15 ). In the second group, ICP normalized whereas the final ventricular size varied depending on the reexpansion of the brain and its natural growth (Figs. 16 and 17) . In both groups, OSV insertion restored a normal ICP pattern.
In one child with a post-shunt slit-ventricle syndrome, the low-resistance DP valve, which was not obstructed, was replaced by an OSV but the catheters were not changed. Normalization of ICP occurred progressively within 2 weeks while the ventricles recovered to a normal size within 10 days 44 (Fig. 18) .
Discussion
In hydrocephalic patients treated with CSF shunting, flow through the shunt must be controlled. The opening pressure of the valve is the DP necessary to initiate drainage; it does not determine the flow rate once the shunt is operating. For a given DP, the flow rate is related to the resistance of the valve: the greater the resistance, the lower the flow rate. 7,26,79' 84 Therefore, the valve specifications should include not only the opening pressure, which does not fully reflect the operating characteristics of shunts, but also the resistance. Currently available valves can be categorized into two groups: low-resistance valves (the spring-ball variety such as the Hakim valve, or the system with a siliconerubber diaphragm such as the Heyer-Schulte valve), and high-resistance valves (silicone-rubber slit valves such as the Holter valve).
When patients are in the upright position, there is constant overdrainage with conventional DP valves (more important with low-resistance than with highresistance shunts), since DP increases whereas resistance is practically stable. Fox, et a/., 26'6I reported large negative ICP values in shunted patients in the upright position. With DP shunts, overdrainage can also occur in other circumstances associated with temporary physiological ICP increases, such as REM sleep or exertion. Several attempts have been made to remedy the problem of overdrainage. The selection of "more physiological" sites for CSF drainage has been suggested, such as the sagittal s i n u s 94 o r placing the distal catheter in the internal jugular vein against the direction of blood flow. 21 This is a good remedy in theory, but creates surgical problems. Another proposed solution is to increase the resistance of the shunt. Buchheit, et al., 7 suggested that the resistance of the shunt should be determined by the patient's height. Yamada ~~ uses a throttle connected to the shunt to increase its resistance. However, these solutions carry the risk of underdrainage when the DP is close to the opening pressure level.
An externally adjustable opening pressure has also been suggested; however, to solve the problem of overdrainage the valve would have to be manipulated every time the DP changed. The solution offered by the OSV relies on control of the CSF flow not on primary regulation of the ICP, which is a highly variable parameter. 11,41,56,86,88 The principle of operation of the OSV is to drain off the CSF that cannot be reabsorbed through natural channels under physiological ICP's. Thus, the OSV avoids the criticisms to which the other shunts are subject; however, the determination of its parameters (level of opening pressure, flow regulation, and safety pressure) presents difficulties. Since the CSF flow is stabilized by the OSV when the DP is large (such as when the patient is erect), the opening pressure plays a role only when the DP is small (such as when the patient is supine). Taking into account, on the one hand, the ICP values reported in infants, children, and adults, 5.19.64.65.74,82,1~ and on the other hand, the abdominal pressure values, 7 we assumed that an opening pressure between 3 and 5 m m Hg would result in normal ICP's when the DP is small. The determination of the level at which CSF flow should be controlled was based on the CSF secretion rates and flow rates through shunts generally accepted in the literature.
In most recent studies, it is concluded that the CSF secretion rate is constant (at least on the average over each nycterohemeral period), its values varying from 0.3 to 0.5 m l / m i n . 13-15'57"6~ Within certain limits, CSF secretion is independent of ICP and, except for some very rare cases (such as papillomas of the choroid plexus,20,~02 and the cases of Cutler, et al., 12 and Rayport and Reiss84), hydrocephalus is not the consequence of CSF oversecretion.
Other information that would help to determine the best flow regulation level includes CSF flow through natural channels compared with that through shunts. Flow of CSF through shunts has rarely been studied in vivo; de Rougemont, et a/., 16"17 reported that CSF flow rates through shunts were slightly lower than the CSF secretion rates measured in children by Cutler, et al. 13 Sato, et al., 91 concluded that "the shunt function would be quite adequate when the flow rates are between 0.1 and 0.3 ml/min." Hara, eta/., 36,7Z found daily flow rates through shunts to be below 350 ml; however, they observed nycterohemeral fluctuations of between 0.05 and 0.78 ml/min. Since the shunts studied were conventional DP shunts, it is very likely that the large CSF flows were measured during overdrainage periods such as related to R E M sleep or an orthostatic position. If this is true, these values should not be taken into account.
Since it is difficult to determine for each patient the precise ratio of CSF that should be drained through the shunt, and since underdrainage is not desirable, it was decided to set the flow regulation level at 20 to 25 ml/ hr; that is, at about the mean rate of CSF secretion. It is obvious that in m a n y children this flow rate will be greater than the patient's drainage requirements. This overdrainage, 50 times smaller than with conventional DP valves, appears to be acceptable, at least for a beginning. In the worst possible situation (that of a patient with very low excess CSF flow rate), the OSV should avoid the abrupt ICP variations that are probably responsible for postoperative cerebral fluid collections. The point on the flow-pressure curve at which flow control ends (also designated as the "blow-off point") has been set at a DP of 30 m m Hg. This safety pressure level has been chosen because it is comparable to the negative ICP recorded in shunted adults in the upright position 61 and because it is approximately the maximal value reached in physiological ICP variations. 88 The number of patients treated with the OSV does not allow definitive conclusions. Other clinical trials will be necessary to determine whether one type or several types of OSV, each with different flow regulation levels, will be necessary to treat all patients. It is already certain that the OSV restores an 1CP curve with normal physiological variations and that the postoperative evolution of ventricular dilatation is similar to that observed after ventriculocisternostomy 4~ (that is, after restoration of normal CSF absorption). Whether or not this will have any effect on the postoperative mechanical or functional complications remains to be demonstrated by more clinical trials.
